OCEA
Ocean Biomedical, Inc.
Key Financials
Net Income
$-9480000
↓ 19.4%
Operating Income
$-3798000
↑ 62.8%
Total Liabilities
$98.5M
↑ 1.2%
Total Assets
$902000.00
↓ 83.6%
EPS (Diluted)
$-0.34
↓ 17.2%
Shareholders' Equity
$-97616000.00
↓ 1.4%
Cash & Equivalents
$0.00
N/A
Operating Cash Flow
$-4180000.00
↓ 141.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| NT 10-Q | 8/14/2025 | View on SEC |
| 25-NSE | 8/8/2025 | View on SEC |
| 8-K | 8/5/2025 | View on SEC |
| 8-K | 7/23/2025 | View on SEC |
| 8-K | 7/16/2025 | View on SEC |
| 8-K | 6/13/2025 | View on SEC |
| 10-Q | 5/15/2025 | View on SEC |
| 10-K/A | 4/29/2025 | View on SEC |
| 8-K | 4/23/2025 | View on SEC |
| 10-K | 4/8/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | OCEA |
| Company Name | Ocean Biomedical, Inc. |
| CIK | 1869974 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (646) 908-2658 |